Financial Architects (New Jersey)’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Hold |
0
| – | – | – | 1279 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1332 |
|
|
2017
Q4 | – | Sell |
-3,206
| Closed | -$272K | – | 1405 |
|
|
2017
Q3 | $272K | Buy |
+3,206
| New | +$272K | 0.05% | 244 |
|
|
2016
Q1 | – | Sell |
-6,412
| Closed | -$434K | – | 1124 |
|
|
2015
Q4 | $434K | Hold |
6,412
| – | – | 0.17% | 122 |
|
|
2015
Q3 | $343K | Hold |
6,412
| – | – | 0.14% | 138 |
|
|
2015
Q2 | $404K | Hold |
6,412
| – | – | 0.15% | 121 |
|
|
2015
Q1 | $308K | Hold |
6,412
| – | – | 0.12% | 135 |
|
|
2014
Q4 | $213K | Buy |
+6,412
| New | +$213K | 0.09% | 162 |
|